295 results
Page 12 of 15
8-K
EX-99.1
qlsy7kl9dekwy
26 Oct 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
dl8a9
22 Oct 10
Other Events
12:00am
8-K
EX-99.1
6m28vp1
14 Oct 10
Regulation FD Disclosure
12:00am
8-K
EX-99.2
vbq6a is62ru6z
12 Oct 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
kjg773y
12 Oct 10
Entry into a Material Definitive Agreement
12:00am
424B3
vbjvivdyktfkr
24 Jun 10
Prospectus supplement
12:00am
8-K
EX-99.1
y4r plnxaye3nrp9gj
11 Jun 10
BioTime Forms New Subsidiary, OrthoCyte Corporation, to Develop Treatments for Orthopedic Conditions Using Stem Cell Technology
12:00am
8-K
EX-99.1
dvvu9
16 Mar 10
Biotime, Inc. Reports Peer-reviewed Scientific Publication on the Reversal of the Developmental Aging of Normal Human Cells
12:00am
8-K
EX-99.1
v64r0jqco 4lwjr8l
10 Mar 10
Biotime Announces Fourth Quarter and Fiscal Year-end 2009
12:00am
POS AM
oxs5h 4sudc68obdir8
7 Jan 10
Prospectus update (post-effective amendment)
12:00am
8-K
EX-99.1
4i730mnpgsnmo3
7 Jan 10
BioTime Subsidiary OncoCyte Corporation Receives
12:00am
8-K
ao6epqrjao
6 Jan 10
Other Events
12:00am